Theratechnologies Inc (TSE:TH) shares reached a new 52-week low on Wednesday . The company traded as low as C$8.03 and last traded at C$7.98, with a volume of 159387 shares changing hands. The stock had previously closed at C$8.39.
A number of research analysts have recently weighed in on the company. National Bank Financial restated an “outperform” rating and issued a C$14.25 target price on shares of Theratechnologies in a report on Wednesday, June 20th. Canaccord Genuity raised their target price on Theratechnologies from C$13.00 to C$14.50 in a report on Friday, July 6th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a C$11.00 target price on shares of Theratechnologies in a report on Tuesday, September 4th.
Theratechnologies Company Profile (TSE:TH)
Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada.
See Also: What is a Leveraged Buyout (LBO)?
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.